?

Treatment targeting**: Beyond cholinesterase inhibitors, what novel targets could address VH? PPN stimulation? Targeted cholinergic agents? Predictive coding modulators (e.g., NMDA antagonists)?

active
open question Created: 2026-04-25T20:28:15 By: backfill_open_questions Quality: 50% ✓ SciDEX ID: open_question-3d3e6b5d-4ee7-4f0a-980a-f1
Open Question open Wiki: mechanisms-visual-hallucinations-dlb
Treatment targeting**: Beyond cholinesterase inhibitors, what novel targets could address VH? PPN stimulation? Targeted cholinergic agents? Predictive coding modulators (e.g., NMDA antagonists)?
Importance Elo
1500
Field Rank
Rank #1017 in mechanisms
Tractability
0.50
Potential Impact
0.50
Evidence Summary
Extracted from wiki page mechanisms-visual-hallucinations-dlb
Secondary Market
No secondary market activity yet. Learn about share issuance →
Share Holder Leaderboard
No shares issued yet.
Evidence Bearing On This Question
No cross-references found yet. Evidence matching runs daily.
Pairwise Tournament History
No pairwise judgments recorded yet.
Derived Hypotheses And Proposals
No derived artifacts linked yet.
Related Entities
mechanisms
Metadata
statusopen
_origin{'url': None, 'type': 'internal', 'tracked_at': '2026-04-26T03:28:15.541231'}
field_tagmechanisms
source_idmechanisms-visual-hallucinations-dlb
sub_fieldvisual-hallucinations-dlb
source_kindwiki
question_hash017aae323fd319e952ba5cb8cdec6ae770641f0c560aa9c8c30ad3f206237cce
question_textTreatment targeting**: Beyond cholinesterase inhibitors, what novel targets could address VH? PPN stimulation? Targeted cholinergic agents? Predictive coding modulators (e.g., NMDA antagonists)?
importance_elo1500
_schema_version1
evidence_summaryExtracted from wiki page mechanisms-visual-hallucinations-dlb
tractability_score0.5
potential_impact_score0.5
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
1
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.